A severity score for acute necrotizing encephalopathy

Area of Science:

• Pediatric Neurology
• Neurocritical Care

Background:

• Acute Necrotizing Encephalopathy (ANE) is a rare but severe neurological disorder in children.
• Accurate prognostic tools are crucial for managing ANE and guiding treatment strategies.

Purpose of the Study:

• To develop and validate a clinical severity score for predicting neurological outcomes in children with ANE.
• To identify key clinical variables associated with ANE prognosis.

Main Methods:

• Retrospective analysis of clinical data and neurological outcomes in two cohorts of pediatric ANE patients (total N=73).
• Development of the ANE severity score (ANE-SS) based on variables correlating with outcome.
• Validation of the ANE-SS in a separate patient cohort.

Main Results:

• The ANE severity score (ANE-SS) incorporates shock, brain stem lesions, age (>48 months), low platelet count, and elevated CSF protein.
• Patients were stratified into low (0-1), medium (2-4), and high (5-9) risk categories based on ANE-SS.
• The ANE-SS demonstrated a significant correlation with neurological outcome in the combined patient cohort.

Conclusions:

• The developed ANE severity score (ANE-SS) is a reliable tool for predicting prognosis in pediatric ANE patients.
• The findings highlight the need for developing more effective treatments for high-risk ANE patients.